1. Home
  2. TNGX vs FRST Comparison

TNGX vs FRST Comparison

Compare TNGX & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • FRST
  • Stock Information
  • Founded
  • TNGX 2014
  • FRST 2004
  • Country
  • TNGX United States
  • FRST United States
  • Employees
  • TNGX N/A
  • FRST N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • FRST Major Banks
  • Sector
  • TNGX Health Care
  • FRST Finance
  • Exchange
  • TNGX Nasdaq
  • FRST Nasdaq
  • Market Cap
  • TNGX 317.4M
  • FRST 290.5M
  • IPO Year
  • TNGX N/A
  • FRST 2006
  • Fundamental
  • Price
  • TNGX $1.37
  • FRST $9.75
  • Analyst Decision
  • TNGX Strong Buy
  • FRST Buy
  • Analyst Count
  • TNGX 7
  • FRST 1
  • Target Price
  • TNGX $12.33
  • FRST $14.00
  • AVG Volume (30 Days)
  • TNGX 789.1K
  • FRST 79.2K
  • Earning Date
  • TNGX 05-07-2025
  • FRST 04-24-2025
  • Dividend Yield
  • TNGX N/A
  • FRST 4.14%
  • EPS Growth
  • TNGX N/A
  • FRST N/A
  • EPS
  • TNGX N/A
  • FRST N/A
  • Revenue
  • TNGX $42,069,000.00
  • FRST $107,704,000.00
  • Revenue This Year
  • TNGX N/A
  • FRST $40.41
  • Revenue Next Year
  • TNGX N/A
  • FRST $12.70
  • P/E Ratio
  • TNGX N/A
  • FRST N/A
  • Revenue Growth
  • TNGX 15.17
  • FRST N/A
  • 52 Week Low
  • TNGX $1.33
  • FRST $9.52
  • 52 Week High
  • TNGX $12.02
  • FRST $13.52
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 26.22
  • FRST 38.52
  • Support Level
  • TNGX $1.48
  • FRST $9.82
  • Resistance Level
  • TNGX $1.66
  • FRST $10.22
  • Average True Range (ATR)
  • TNGX 0.16
  • FRST 0.29
  • MACD
  • TNGX -0.01
  • FRST 0.01
  • Stochastic Oscillator
  • TNGX 5.63
  • FRST 13.82

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.

Share on Social Networks: